Raman Spectral Library for Counterfeit Detection
Posted on July 28, 2014
By: Yvette L. Loethen, ORISE Post-Doctoral Fellow
Jason Rodriguez, Chemist
FDA
The global supply chain of medicines is vulnerable to adulteration and introduction of counterfeit products.1 According to the World Health Organization, counterfeit drug products may contain less active pharmaceutical ingredient (API) than the amount listed on the packaging (sub-standard), no API, ...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
Anti-Counterfeiting, API, counterfeit, excipients, FDA, Raman, raman spectral library, WHO
Related Product Videos
The Raw Material Identification Difference - Rigaku Raman Technologies
Related Products
Monitoring the Quality of Medicines - Rigaku Raman TechnologiesSubscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
